biguanides has been researched along with Keratoderma Blennorrhagicum in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonis, ST | 1 |
| Clark, WB | 1 |
| Shklar, G | 1 |
| Almeyda, J | 1 |
| Baker, H | 1 |
1 review available for biguanides and Keratoderma Blennorrhagicum
| Article | Year |
|---|---|
Drug reactions. X. Adverse cutaneous reactions to hypoglycaemic agents.
Topics: Antigens; Biguanides; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Erythema | 1970 |
1 trial available for biguanides and Keratoderma Blennorrhagicum
| Article | Year |
|---|---|
Chlorhexidine-induced lingual keratosis and dysplasia in rats.
Topics: Animals; Biguanides; Cell Nucleus; Chlorhexidine; Clinical Trials as Topic; Cytoplasm; Double-Blind | 1978 |